nodes	percent_of_prediction	percent_of_DWPC	metapath
Procaine—Eruption—Furosemide—dilated cardiomyopathy	0.0359	0.046	CcSEcCtD
Procaine—Benzocaine—SCN5A—dilated cardiomyopathy	0.0303	0.334	CrCbGaD
Procaine—Laryngeal oedema—Lisinopril—dilated cardiomyopathy	0.0258	0.0331	CcSEcCtD
Procaine—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.0252	0.0323	CcSEcCtD
Procaine—SCN10A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.023	0.18	CbGpPWpGaD
Procaine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0227	0.0291	CcSEcCtD
Procaine—Procainamide—SCN5A—dilated cardiomyopathy	0.0197	0.217	CrCbGaD
Procaine—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.0178	0.0227	CcSEcCtD
Procaine—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.017	0.0218	CcSEcCtD
Procaine—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.0166	0.0212	CcSEcCtD
Procaine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.0159	0.0203	CcSEcCtD
Procaine—Neuropathy—Lisinopril—dilated cardiomyopathy	0.0156	0.0199	CcSEcCtD
Procaine—Probenecid—SLC22A5—dilated cardiomyopathy	0.0148	0.163	CrCbGaD
Procaine—Aminohippurate—SLC22A5—dilated cardiomyopathy	0.0146	0.161	CrCbGaD
Procaine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.0145	0.0185	CcSEcCtD
Procaine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.0142	0.0182	CcSEcCtD
Procaine—Eosinophilia—Furosemide—dilated cardiomyopathy	0.0137	0.0176	CcSEcCtD
Procaine—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.0133	0.0171	CcSEcCtD
Procaine—Somnolence—Spironolactone—dilated cardiomyopathy	0.0129	0.0165	CcSEcCtD
Procaine—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.0124	0.0159	CcSEcCtD
Procaine—Drowsiness—Furosemide—dilated cardiomyopathy	0.0124	0.0158	CcSEcCtD
Procaine—Urticaria—Spironolactone—dilated cardiomyopathy	0.0115	0.0147	CcSEcCtD
Procaine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.0115	0.0147	CcSEcCtD
Procaine—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.0114	0.0146	CcSEcCtD
Procaine—Procainamide—SLC22A5—dilated cardiomyopathy	0.0114	0.125	CrCbGaD
Procaine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.0107	0.0137	CcSEcCtD
Procaine—Tinnitus—Furosemide—dilated cardiomyopathy	0.0103	0.0132	CcSEcCtD
Procaine—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.0103	0.0132	CcSEcCtD
Procaine—Pruritus—Spironolactone—dilated cardiomyopathy	0.0103	0.0131	CcSEcCtD
Procaine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.0101	0.013	CcSEcCtD
Procaine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00992	0.0127	CcSEcCtD
Procaine—Erythema—Furosemide—dilated cardiomyopathy	0.00966	0.0124	CcSEcCtD
Procaine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00958	0.0123	CcSEcCtD
Procaine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00921	0.0118	CcSEcCtD
Procaine—Rash—Spironolactone—dilated cardiomyopathy	0.00914	0.0117	CcSEcCtD
Procaine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00913	0.0117	CcSEcCtD
Procaine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00911	0.0117	CcSEcCtD
Procaine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00909	0.0116	CcSEcCtD
Procaine—Agitation—Furosemide—dilated cardiomyopathy	0.00888	0.0114	CcSEcCtD
Procaine—SCN10A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00882	0.0691	CbGpPWpGaD
Procaine—Leukopenia—Furosemide—dilated cardiomyopathy	0.00865	0.0111	CcSEcCtD
Procaine—Nausea—Spironolactone—dilated cardiomyopathy	0.00861	0.011	CcSEcCtD
Procaine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00848	0.0108	CcSEcCtD
Procaine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00829	0.0106	CcSEcCtD
Procaine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00789	0.0101	CcSEcCtD
Procaine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00776	0.00993	CcSEcCtD
Procaine—Shock—Furosemide—dilated cardiomyopathy	0.00776	0.00993	CcSEcCtD
Procaine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00772	0.00988	CcSEcCtD
Procaine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00762	0.00975	CcSEcCtD
Procaine—Chills—Lisinopril—dilated cardiomyopathy	0.00747	0.00956	CcSEcCtD
Procaine—Hypotension—Furosemide—dilated cardiomyopathy	0.00737	0.00943	CcSEcCtD
Procaine—Erythema—Lisinopril—dilated cardiomyopathy	0.00725	0.00928	CcSEcCtD
Procaine—Tension—Lisinopril—dilated cardiomyopathy	0.00711	0.0091	CcSEcCtD
Procaine—Nervousness—Lisinopril—dilated cardiomyopathy	0.00704	0.00901	CcSEcCtD
Procaine—Somnolence—Furosemide—dilated cardiomyopathy	0.00701	0.00897	CcSEcCtD
Procaine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00683	0.00874	CcSEcCtD
Procaine—Fatigue—Furosemide—dilated cardiomyopathy	0.0068	0.0087	CcSEcCtD
Procaine—Tremor—Lisinopril—dilated cardiomyopathy	0.00679	0.00869	CcSEcCtD
Procaine—Angioedema—Lisinopril—dilated cardiomyopathy	0.00662	0.00848	CcSEcCtD
Procaine—Syncope—Lisinopril—dilated cardiomyopathy	0.0065	0.00832	CcSEcCtD
Procaine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00649	0.0083	CcSEcCtD
Procaine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00637	0.00815	CcSEcCtD
Procaine—Urticaria—Furosemide—dilated cardiomyopathy	0.00626	0.00801	CcSEcCtD
Procaine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00623	0.00798	CcSEcCtD
Procaine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00617	0.0079	CcSEcCtD
Procaine—Anxiety—Lisinopril—dilated cardiomyopathy	0.00615	0.00787	CcSEcCtD
Procaine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00592	0.00757	CcSEcCtD
Procaine—Oedema—Lisinopril—dilated cardiomyopathy	0.00592	0.00757	CcSEcCtD
Procaine—HTR3A—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00588	0.0461	CbGpPWpGaD
Procaine—Shock—Lisinopril—dilated cardiomyopathy	0.00582	0.00745	CcSEcCtD
Procaine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00581	0.00743	CcSEcCtD
Procaine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00579	0.00741	CcSEcCtD
Procaine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00577	0.00739	CcSEcCtD
Procaine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00572	0.00732	CcSEcCtD
Procaine—Pruritus—Furosemide—dilated cardiomyopathy	0.00558	0.00714	CcSEcCtD
Procaine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00553	0.00707	CcSEcCtD
Procaine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00539	0.0069	CcSEcCtD
Procaine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00539	0.0069	CcSEcCtD
Procaine—Somnolence—Lisinopril—dilated cardiomyopathy	0.00526	0.00673	CcSEcCtD
Procaine—Dizziness—Furosemide—dilated cardiomyopathy	0.00521	0.00667	CcSEcCtD
Procaine—Fatigue—Lisinopril—dilated cardiomyopathy	0.0051	0.00653	CcSEcCtD
Procaine—Vomiting—Furosemide—dilated cardiomyopathy	0.00501	0.00641	CcSEcCtD
Procaine—Rash—Furosemide—dilated cardiomyopathy	0.00497	0.00636	CcSEcCtD
Procaine—Dermatitis—Furosemide—dilated cardiomyopathy	0.00497	0.00636	CcSEcCtD
Procaine—Urticaria—Lisinopril—dilated cardiomyopathy	0.0047	0.00601	CcSEcCtD
Procaine—Nausea—Furosemide—dilated cardiomyopathy	0.00468	0.00599	CcSEcCtD
Procaine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00468	0.00598	CcSEcCtD
Procaine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00436	0.00558	CcSEcCtD
Procaine—BCHE—Glycerophospholipid biosynthesis—TAZ—dilated cardiomyopathy	0.00423	0.0332	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00419	0.0328	CbGpPWpGaD
Procaine—Pruritus—Lisinopril—dilated cardiomyopathy	0.00419	0.00536	CcSEcCtD
Procaine—HTR3A—Ion channel transport—RYR2—dilated cardiomyopathy	0.00407	0.0318	CbGpPWpGaD
Procaine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00405	0.00518	CcSEcCtD
Procaine—HTR3A—Ion channel transport—PLN—dilated cardiomyopathy	0.00396	0.031	CbGpPWpGaD
Procaine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00391	0.00501	CcSEcCtD
Procaine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00376	0.00481	CcSEcCtD
Procaine—Rash—Lisinopril—dilated cardiomyopathy	0.00373	0.00477	CcSEcCtD
Procaine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00373	0.00477	CcSEcCtD
Procaine—Nausea—Lisinopril—dilated cardiomyopathy	0.00351	0.0045	CcSEcCtD
Procaine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00348	0.0272	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—SCN5A—dilated cardiomyopathy	0.00333	0.0261	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.00314	0.0246	CbGpPWpGaD
Procaine—BCHE—Phospholipid metabolism—TAZ—dilated cardiomyopathy	0.00295	0.0231	CbGpPWpGaD
Procaine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00283	0.0222	CbGpPWpGaD
Procaine—CHRNA2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00261	0.0205	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.00238	0.0186	CbGpPWpGaD
Procaine—SCN10A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.00233	0.0182	CbGpPWpGaD
Procaine—CHRNA2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00209	0.0164	CbGpPWpGaD
Procaine—SLC6A3—Monoamine Transport—AGT—dilated cardiomyopathy	0.00201	0.0158	CbGpPWpGaD
Procaine—CHRNA2—Neuronal System—ACTN2—dilated cardiomyopathy	0.002	0.0157	CbGpPWpGaD
Procaine—SCN10A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.00187	0.0146	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00164	0.0128	CbGpPWpGaD
Procaine—BCHE—Peptide hormone metabolism—ACE—dilated cardiomyopathy	0.00148	0.0116	CbGpPWpGaD
Procaine—BCHE—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00144	0.0113	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00142	0.0111	CbGpPWpGaD
Procaine—SLC6A3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00142	0.0111	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00142	0.0111	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—PSEN2—dilated cardiomyopathy	0.00141	0.011	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00138	0.0108	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00138	0.0108	CbGpPWpGaD
Procaine—SLC6A3—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00129	0.0101	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00128	0.01	CbGpPWpGaD
Procaine—BCHE—Neuronal System—ABCC9—dilated cardiomyopathy	0.00115	0.00903	CbGpPWpGaD
Procaine—SLC6A3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00113	0.00886	CbGpPWpGaD
Procaine—BCHE—Neuronal System—ACTN2—dilated cardiomyopathy	0.00111	0.00866	CbGpPWpGaD
Procaine—SLC6A3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00109	0.0085	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00101	0.00792	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.001	0.00786	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000951	0.00745	CbGpPWpGaD
Procaine—BCHE—Peptide hormone metabolism—AGT—dilated cardiomyopathy	0.000938	0.00735	CbGpPWpGaD
Procaine—SLC6A3—Monoamine Transport—TNF—dilated cardiomyopathy	0.000912	0.00714	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000879	0.00689	CbGpPWpGaD
Procaine—SCN10A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.00085	0.00666	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.000822	0.00644	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.000822	0.00644	CbGpPWpGaD
Procaine—HTR3A—Ion channel transport—RAF1—dilated cardiomyopathy	0.000802	0.00628	CbGpPWpGaD
Procaine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000791	0.0062	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—RAC1—dilated cardiomyopathy	0.000707	0.00554	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000673	0.00527	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000655	0.00513	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000655	0.00513	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000627	0.00491	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000608	0.00477	CbGpPWpGaD
Procaine—CHRNA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000595	0.00466	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00054	0.00423	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—CD36—dilated cardiomyopathy	0.000535	0.00419	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—RAC1—dilated cardiomyopathy	0.000504	0.00395	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—RAF1—dilated cardiomyopathy	0.000469	0.00367	CbGpPWpGaD
Procaine—CHRNA2—Neuronal System—RAF1—dilated cardiomyopathy	0.000456	0.00357	CbGpPWpGaD
Procaine—BCHE—Metabolism—ANKRD1—dilated cardiomyopathy	0.000451	0.00353	CbGpPWpGaD
Procaine—BCHE—Metabolism—TAZ—dilated cardiomyopathy	0.000424	0.00332	CbGpPWpGaD
Procaine—BCHE—Metabolism—SDHA—dilated cardiomyopathy	0.000383	0.003	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—RAF1—dilated cardiomyopathy	0.000334	0.00262	CbGpPWpGaD
Procaine—BCHE—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000328	0.00257	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—LMNA—dilated cardiomyopathy	0.000324	0.00253	CbGpPWpGaD
Procaine—SLC6A3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000322	0.00252	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—EGFR—dilated cardiomyopathy	0.000321	0.00252	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—ACE—dilated cardiomyopathy	0.000279	0.00219	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000279	0.00219	CbGpPWpGaD
Procaine—BCHE—Neuronal System—RAF1—dilated cardiomyopathy	0.000252	0.00197	CbGpPWpGaD
Procaine—SLC6A3—Neuronal System—RAF1—dilated cardiomyopathy	0.000247	0.00193	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000234	0.00183	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—EGFR—dilated cardiomyopathy	0.000229	0.0018	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000228	0.00178	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—TNF—dilated cardiomyopathy	0.000218	0.00171	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000205	0.00161	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—AGT—dilated cardiomyopathy	0.000177	0.00139	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000133	0.00104	CbGpPWpGaD
Procaine—BCHE—Metabolism—GPX1—dilated cardiomyopathy	0.000104	0.000815	CbGpPWpGaD
Procaine—BCHE—Metabolism—CD36—dilated cardiomyopathy	0.000101	0.000794	CbGpPWpGaD
Procaine—BCHE—Metabolism—AGT—dilated cardiomyopathy	9.13e-05	0.000715	CbGpPWpGaD
